Highlights of the 35th European Cystic Fibrosis Conference; Part 2

 e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 3, Part 2)

 

Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:  

  •  Identify therapies associated with long-term reductions in mortality.

  •  Describe the “low volume” hypothesis relative to recent research in new sodium channel blockers.

  •  Discuss new findings describing the CF neonate lung based on measurement via LCI and HRCT.

  • Explain the importance of residual chloride function in selecting patients suitable for treatment with ivacaftor.

  • Summarize the effects of ataluren in FEV1 and rate of exacerbations in patients with nonsense mutations.

Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
11/13/2012
Registration closes: 
11/12/2014
Cost:
$0.00
 
Peter J. Mogayzel, Jr, MD, PhD, MBA
Associate Professor of Pediatrics
Director, Johns Hopkins University School of Medicine Cystic Fibrosis Center
Baltimore, MD

Stefanie Petrou-Binder, MD
Medical Writer
Berlin, Germany

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.